The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein–coupled receptors

Yazar: Yan, Yibing, Shirakabe, Kyoko, Werb, Zena
Baskı/Yayın Bilgisi 2002

Robust network inference using response logic

Yazar: Gross, Torsten, Wongchenko, Matthew J, Yan, Yibing, Blüthgen, Nils
Yayımlandı Bioinformatics (2019)

The cancer cell proteome and transcriptome predicts sensitivity to targeted and cytotoxic drugs

Yazar: Rydenfelt, Mattias, Wongchenko, Matthew, Klinger, Bertram, Yan, Yibing, Blüthgen, Nils
Yayımlandı Life Sci Alliance (2019)

Topological Organization Alterations of Whole-Brain Functional Networks in Patients with Childhood Absence Epilepsy: Associations with Treatment Effects

Yazar: Wang, Xueyu, Fang, Peng, Jiao, Dongmei, Hu, Tian, Yang, Qi, Liang, Wei, Li, Yijun, Yan, Yibing, Liu, Libo
Yayımlandı Dis Markers (2021)

HSP105 Recruits Protein Phosphatase 2A To Dephosphorylate β-Catenin

Yazar: Yu, Nancy, Kakunda, Michael, Pham, Victoria, Lill, Jennie R., Du, Pan, Wongchenko, Matthew, Yan, Yibing, Firestein, Ron, Huang, XiaoDong
Yayımlandı Mol Cell Biol (2015)

Biomarker analysis of on-treatment and at progression biopsies from BRIM7 - a phase 1B trial of combined vemurafenib and cobimetinib treatment in BRAF V600 mutated melanoma

Yazar: Yan, Yibing, McArthur, Grant, Hamid, Omid, Puzanov, Igor, Gonzalez, Rene, Gajewski, Thomas, Wang, Yulei, Wongchenko, Matthew, Choong, Nicholas, Ribas, Antoni
Baskı/Yayın Bilgisi 2014

Improved Cognitive Promotion through Accelerated Magnetic Stimulation

Yazar: Wu, Xingqi, Wang, Lu, Geng, Zhi, Wei, Ling, Yan, Yibing, Xie, Chengjuan, Chen, Xingui, Ji, Gong-Jun, Tian, Yanghua, Wang, Kai
Yayımlandı eNeuro (2021)

Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice

Yazar: Carlson, Timothy R., Yan, Yibing, Wu, Xiaoqing, Lam, Michael T., Tang, Gale L., Beverly, Levi J., Messina, Louis M., Capobianco, Anthony J., Werb, Zena, Wang, Rong
Baskı/Yayın Bilgisi 2005

Network quantification of EGFR signaling unveils potential for targeted combination therapy

Yazar: Klinger, Bertram, Sieber, Anja, Fritsche-Guenther, Raphaela, Witzel, Franziska, Berry, Leanne, Schumacher, Dirk, Yan, Yibing, Durek, Pawel, Merchant, Mark, Schäfer, Reinhold, Sers, Christine, Blüthgen, Nils
Baskı/Yayın Bilgisi 2013

Amphiregulin and PTEN evoke a multimodal mechanism of acquired resistance to PI3K inhibition

Yazar: Edgar, Kyle A., Crocker, Lisa, Cheng, Eric, Wagle, Marie-Claire, Wongchenko, Matthew, Yan, Yibing, Wilson, Timothy R., Dompe, Nicholas, Neve, Richard M., Belvin, Marcia, Sampath, Deepak, Friedman, Lori S., Wallin, Jeffrey J.
Baskı/Yayın Bilgisi 2014

Impact of depth of response on survival in patients treated with cobimetinib ± vemurafenib: pooled analysis of BRIM-2, BRIM-3, BRIM-7 and coBRIM

Yazar: Lewis, Karl D., Larkin, James, Ribas, Antoni, Flaherty, Keith T., McArthur, Grant A., Ascierto, Paolo A., Dréno, Brigitte, Yan, Yibing, Wongchenko, Matthew, McKenna, Edward, Zhu, Qian, Mun, Yong, Hauschild, Axel
Yayımlandı Br J Cancer (2019)

Extended 5-Year Follow-Up Results of a Phase 1b Study (BRIM7) of Vemurafenib and Cobimetinib in BRAF-Mutant Melanoma

Yazar: Ribas, Antoni, Daud, Adil, Pavlick, Anna C., Gonzalez, Rene, Lewis, Karl D., Hamid, Omid, Gajewski, Thomas F., Puzanov, Igor, Wongchenko, Matthew, Rooney, Isabelle, Hsu, Jessie J., Yan, Yibing, Park, Erica, McArthur, Grant A.
Yayımlandı Clin Cancer Res (2019)

Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors

Yazar: Wilson, Timothy R., Fridlyand, Jane, Yan, Yibing, Penuel, Elicia, Burton, Luciana, Chan, Emily, Peng, Jing, Lin, Eva, Wang, Yulei, Sosman, Jeff, Ribas, Antoni, Li, Jiang, Moffat, John, Sutherlin, Daniel P., Koeppen, Hartmut, Merchant, Mark, Neve, Richard, Settleman, Jeff
Baskı/Yayın Bilgisi 2012

Therapeutic resistance and susceptibility is shaped by cooperative multi-compartment tumor adaptation

Yazar: Long, Jason E., Wongchenko, Matthew J., Nickles, Dorothee, Chung, Wei-Jen, Wang, Bu-er, Riegler, Johannes, Li, Ji, Li, Qingling, Sandoval, Wendy, Eastham-Anderson, Jeff, Modrusan, Zora, Junttila, Teemu, Carano, Richard A. D., Foreman, Oded, Yan, Yibing, Junttila, Melissa R.
Yayımlandı Cell Death Differ (2019)

Critical role for Syk in responses to vascular injury

Yazar: Andre, Patrick, Morooka, Toshifumi, Sim, Derek, Abe, Keith, Lowell, Clifford, Nanda, Nisha, Delaney, Suzanne, Siu, Gail, Yan, Yibing, Hollenbach, Stan, Pandey, Anjali, Gao, Huiyun, Wang, Yunmei, Nakajima, Kohsuke, Parikh, Sahil A., Shi, Can, Phillips, David, Owen, Whyte, Sinha, Uma, Simon, Daniel I.
Baskı/Yayın Bilgisi 2011

Development of a robust flow cytometry-based pharmacodynamic assay to detect phospho-protein signals for phosphatidylinositol 3-kinase inhibitors in multiple myeloma

Yazar: Li, Congfen, Takahashi, Chikara, Zhang, Liangxuan, Huseni, Mahrukh, Stankovich, Basha, Mashhedi, Haider, Lee, Joanna, French, Dorothy, Anderson, Jeff Eastham, Kim, Doris, Howell, Kathy, Brauer, Matthew J, Kowanetz, Marcin, Yan, Yibing, Humke, Eric, Ebens, Allen, Hampton, Garret, Lackner, Mark R, Hegde, Priti, Jia, Shidong
Baskı/Yayın Bilgisi 2013

Genomic features of exceptional response in vemurafenib ± cobimetinib–treated patients with BRAF(V600)-mutated metastatic melanoma

Yazar: Yan, Yibing, Wongchenko, Matthew J., Robert, Caroline, Larkin, James, Ascierto, Paolo A., Dréno, Brigitte, Maio, Michele, Garbe, Claus, Chapman, Paul B., Sosman, Jeffrey A., Shi, Zhen, Koeppen, Hartmut, Hsu, Jessie J., Chang, Ilsung, Caro, Ivor, Rooney, Isabelle, McArthur, Grant A., Ribas, Antoni
Yayımlandı Clin Cancer Res (2019)

A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors

Yazar: Saura, Cristina, Roda, Desamparados, Roselló, Susana, Oliveira, Mafalda, Macarulla, Teresa, Pérez-Fidalgo, José Alejandro, Morales-Barrera, Rafael, Sanchis-García, Juan Manuel, Musib, Luna, Budha, Nageshwar, Zhu, Jin, Nannini, Michelle, Chan, Wai Y., Sanabria Bohórquez, Sandra M., Meng, Raymond D., Lin, Kui, Yan, Yibing, Patel, Premal, Baselga, José, Tabernero, Josep, Cervantes, Andrés
Yayımlandı Cancer Discov (2016)

Distinct molecular profiles and immunotherapy treatment outcomes of V600E and V600K BRAF-mutant melanoma

Yazar: da Silva, Inês Pires, Wang, Kevin YX, Wilmott, James S, Holst, Jeff, Carlino, Matteo S, Park, John J, Quek, Camelia, Wongchenko, Matthew, Yan, Yibing, Mann, Graham, Johnson, Douglas B., McQuade, Jennifer L, Rai, Rajat, Kefford, Richard F, Rizos, Helen, Scolyer, Richard A, Yang, Jean YU, Long, Georgina V, Menzies, Alexander M
Yayımlandı Clin Cancer Res (2019)

First-in-human Phase I study of Pictilisib (GDC-0941), a potent pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor, in patients with advanced solid tumors

Yazar: Sarker, Debashis, Ang, Joo Ern, Baird, Richard, Kristeleit, Rebecca, Shah, Krunal, Moreno, Victor, Clarke, Paul A., Raynaud, Florence I., Levy, Gallia, Ware, Joseph A, Mazina, Kathryn, Lin, Ray, Wu, Jenny, Fredrickson, Jill, Spoerke, Jill M, Lackner, Mark R, Yan, Yibing, Friedman, Lori S., Kaye, Stan B., Derynck, Mika K., Workman, Paul, de Bono, Johann S.
Yayımlandı Clin Cancer Res (2014)